Literature DB >> 23508573

Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.

Sodam Kim1, Sun Young Kim, John P Pribis, Michael Lotze, Kevin P Mollen, Richard Shapiro, Patricia Loughran, Melanie J Scott, Timothy R Billiar.   

Abstract

High mobility group box 1 (HMGB1) is a DNA-binding protein that possesses cytokinelike, proinflammatory properties when released extracellularly in the C23-C45 disulfide form. HMGB1 also plays a key role as a mediator of acute and chronic inflammation in models of sterile injury. Although HMGB1 interacts with multiple pattern recognition receptors (PRRs), many of its effects in injury models occur through an interaction with toll-like receptor 4 (TLR4). HMGB1 interacts directly with the TLR4/myeloid differentiation protein 2 (MD2) complex, although the nature of this interaction remains unclear. We demonstrate that optimal HMGB1-dependent TLR4 activation in vitro requires the coreceptor CD14. TLR4 and MD2 are recruited into CD14-containing lipid rafts of RAW264.7 macrophages after stimulation with HMGB1, and TLR4 interacts closely with the lipid raft protein GM1. Furthermore, we show that HMGB1 stimulates tumor necrosis factor (TNF)-α release in WT but not in TLR4(-/-), CD14(-/-), TIR domain-containing adapter-inducing interferon-β (TRIF)(-/-) or myeloid differentiation primary response protein 88 (MyD88)(-/-) macrophages. HMGB1 induces the release of monocyte chemotactic protein 1 (MCP-1), interferon gamma-induced protein 10 (IP-10) and macrophage inflammatory protein 1α (MIP-1α) in a TLR4- and CD14-dependent manner. Thus, efficient recognition of HMGB1 by the TLR4/MD2 complex requires CD14.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23508573      PMCID: PMC3667211          DOI: 10.2119/molmed.2012.00306

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  51 in total

1.  Receptor cluster formation during activation by bacterial products.

Authors:  Martha Triantafilou; Kathy Triantafilou
Journal:  J Endotoxin Res       Date:  2003

2.  Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.

Authors:  Bettina M Buchholz; Timothy R Billiar; Anthony J Bauer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-27       Impact factor: 4.052

Review 3.  HMGB1 as a DNA-binding cytokine.

Authors:  Ulf Andersson; Helena Erlandsson-Harris; Huan Yang; Kevin J Tracey
Journal:  J Leukoc Biol       Date:  2002-12       Impact factor: 4.962

Review 4.  Endotoxin recognition and signal transduction by the TLR4/MD2-complex.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Douglas T Golenbock
Journal:  Microbes Infect       Date:  2004-12       Impact factor: 2.700

5.  TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.

Authors:  Deepak Mittal; Fabiana Saccheri; Emilie Vénéreau; Tobias Pusterla; Marco E Bianchi; Maria Rescigno
Journal:  EMBO J       Date:  2010-06-04       Impact factor: 11.598

6.  High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury.

Authors:  Rong-Rong Zhou; Hong-Bo Liu; Jian-Ping Peng; Yan Huang; Ning Li; Mei-Fang Xiao; Haichao Wang; Xue-Gong Fan
Journal:  Exp Mol Pathol       Date:  2012-05-17       Impact factor: 3.362

7.  High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.

Authors:  Yuji Nadatani; Toshio Watanabe; Tetsuya Tanigawa; Hirohisa Machida; Hirotoshi Okazaki; Hirokazu Yamagami; Kenji Watanabe; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Am J Pathol       Date:  2012-05-22       Impact factor: 4.307

8.  HMGB1 contributes to kidney ischemia reperfusion injury.

Authors:  Huiling Wu; Jin Ma; Peng Wang; Theresa M Corpuz; Usha Panchapakesan; Kate R Wyburn; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

Review 9.  Lipid rafts: heterogeneity on the high seas.

Authors:  Linda J Pike
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

10.  Post-ischemic inflammation in the brain.

Authors:  Takashi Shichita; Ryota Sakaguchi; Mayu Suzuki; Akihiko Yoshimura
Journal:  Front Immunol       Date:  2012-05-31       Impact factor: 7.561

View more
  73 in total

1.  Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Authors:  Anne-Catherine Raby; Chantal S Colmont; Ann Kift-Morgan; Jörg Köhl; Matthias Eberl; Donald Fraser; Nicholas Topley; Mario O Labéta
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  CD14 contributes to warm hepatic ischemia-reperfusion injury in mice.

Authors:  Changchun Cai; Xiaolian Shi; Sebastian Korff; Jinxiang Zhang; Patricia A Loughran; Xiangcai Ruan; Yong Zhang; Li Liu; Timothy R Billiar
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

Review 3.  Understanding the Role of Innate Immunity in the Response to Intracortical Microelectrodes.

Authors:  John K Hermann; Jeffrey R Capadona
Journal:  Crit Rev Biomed Eng       Date:  2018

4.  HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.

Authors:  Jingjing Cai; Hong Yuan; Qingde Wang; Huan Yang; Yousef Al-Abed; Zhong Hua; Jiemei Wang; Dandan Chen; Jinze Wu; Ben Lu; John P Pribis; Weihong Jiang; Kan Yang; David J Hackam; Kevin J Tracey; Timothy R Billiar; Alex F Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

5.  Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages.

Authors:  Juan Wang; Yoram Vodovotz; Liyan Fan; Yuehua Li; Zheng Liu; Rami Namas; Derek Barclay; Ruben Zamora; Timothy R Billiar; Mark A Wilson; Jie Fan; Yong Jiang
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

6.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

7.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

Review 8.  Potential role of High mobility group box 1 in hepatocellular carcinoma.

Authors:  Rong-Rong Zhou; Xu-Yuan Kuang; Yan Huang; Ning Li; Ming-Xiang Zou; Dao-Lin Tang; Xue-Gong Fan
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  Propofol Protects Rats and Human Alveolar Epithelial Cells Against Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting HMGB1 Expression.

Authors:  Xiaoyan Wang; Chengxiao Liu; Gongming Wang
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

10.  Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli.

Authors:  Arezoo Mohammadipoor; Ryang Hwa Lee; Darwin J Prockop; Thomas J Bartosh
Journal:  Transl Res       Date:  2016-07-09       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.